Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by amorakon May 01, 2007 12:41pm
482 Views
Post# 12704388

RE: This sounds familiar....

RE: This sounds familiar....I read it already. Sounds like the stock market. My issue was with perception. Although we know that DM has served shareholders very well by taking the RVX story to the markets, there has never been any indication that he or anybody associated with RVX has manipulated the market in any way. The others you mentioned seem to have done so but I have no issue with RVX and its people, other than get the damn deal done, which they will do, I am confident. But the market is probably being on the low end of fair in its assessment of RVX. Certainly before Phase 1 and probably IND status, RVX is worth $60, meaning that we have a four bagger in front of us. I think that at this point we should be trading at a third to a half of the potential sale price. But at $30 we're looking at a double and I don't think many players will step in for only a double on something like this. So if we're being manipulated, it's just reflecting uncertainty and varied opinion. Sounds like the market.
Bullboard Posts